Form 4: USANA Health Sciences Director Sells Shares Under Pre-Arranged Trading Plan

USANA Health Sciences Director John Turman Fleming sold 500 shares of common stock for approximately $29.66 per share on June 9, 2025, under a Rule 10b5-1 trading plan.

Summary

• John Turman Fleming, a Director of USANA Health Sciences Inc. (USNA), reported a transaction involving the company's common stock.
• On June 9, 2025, Mr. Fleming disposed of 500 shares of common stock.
• The shares were sold at a price of $29.6589 per share.
• The transaction was conducted under a Rule 10b5-1(c) pre-arranged trading plan, indicating it was scheduled in advance.
• Following this transaction, Mr. Fleming beneficially owns 4,200 shares of USANA Health Sciences common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, the fact that it's under a Rule 10b5-1 plan suggests it's a pre-scheduled event for personal liquidity or diversification, rather than a reaction to negative company-specific news. The small number of shares relative to the company's total outstanding shares also limits its significance.

Negatives

• The sale of shares by an insider, even under a pre-arranged plan, can sometimes be perceived as a slight negative signal regarding management's view on future stock performance, though the impact is mitigated by the 10b5-1 plan.

Risks

• While not a direct risk from the filing itself, consistent insider selling over time, even through 10b5-1 plans, could potentially signal a lack of confidence in the company's future prospects by those closest to the operations.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook. It solely reports a past insider transaction.

Industry Context

This specific insider transaction by a director of USANA Health Sciences is an individual event and does not directly reflect broader industry trends. Insider sales, especially those under Rule 10b5-1 plans, are common and often part of personal financial planning rather than a direct signal about the company's immediate industry prospects.

Related Party Transactions

• The transaction involves a director of the company selling shares, which is a type of related party transaction as it involves an insider.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, which could be interpreted by some as a slight negative signal, though its impact is minimal given the pre-arranged nature and small volume.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

Keywords

USANA Health Sciences, USNA, Form 4, insider trading, stock sale, director, John Turman Fleming, beneficial ownership, Rule 10b5-1